Report: Sanofi will invest in Japanese firm to enter generics market

05/26/2010 | Reuters

Sanofi-Aventis will buy a stake of almost 5% in Japan's Nichi-Iko Pharmaceutical for about $55 million in a bid to enter the country's generic-drug market, according to a newspaper report. The companies also plan to create a joint venture and team up in developing bioengineered drugs, the report states.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care